Physician profile
Ibrahim Abd El-Shafy
NPI 1407146392
$44,169.08
in general payments reported to CMS, 2019-2025
7 companies · $24K in 2025
The $24K reported for 2025 was more than what 99% of Surgical Critical Care providers received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $3,373 · 2023: $16K · 2024: $498 · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $37K · Travel and Lodging: $2,367 · Food and Beverage: $1,429.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $37,000.00 |
| Travel and Lodging | $2,367.41 |
| Food and Beverage | $1,428.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $43,821.98 | 2022-2025 | Davinci Xi, Da Vinci Surgical System |
| Haemonetics Corporation | $143.21 | 2024 | Teg6s Hemostasis System |
| Atricure, INC. | $75.96 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $51.30 | 2023-2024 | Andexxa |
| Smith+Nephew, INC. | $39.53 | 2024-2025 | Collagenase Santyl |
| Convatec INC. | $19.54 | 2023 | |
| Ethicon US, LLC | $17.56 | 2023 | Echelon; Endopath, Surgicel Nu-Knit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ibrahim Abd El-Shafy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.